← Back to Company DatabaseVisit Website
Moderna
mRNA therapeutics platform with a growing oncology pipeline.
PublicCambridge, MAFounded 2010
About
Moderna is a biotechnology company leveraging its mRNA platform for therapeutic development across infectious diseases and oncology. In cancer, Moderna is developing personalized cancer vaccines (individualized neoantigen therapy) in partnership with Merck, targeting melanoma and other solid tumors. The company's oncology programs represent a significant portion of its expanding pipeline.
Total Funding
$2.7BKey Product
mRNA-4157/V940 personalized cancer vaccine (with Merck)Geography
North AmericaKey Investors
Flagship PioneeringAstraZenecaMerck
Focus Areas
Treatment (Therapeutics)Drug Discovery
Technology
ImmunotherapyTargeted Therapy
Cancer Types
SkinLungPan-cancer
Last updated: Feb 4, 2026